+1 (704) 266-3234

Global Osteoporosis Therapeutics Market Size, Status And Forecast 2021-2027

Published on: Jul 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 105

Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The osteoporosis therapeutic market has become very competitive due to the high number of new drug approvals, although the majority of them are incremental innovations of existing therapies. Competition is fierce, particularly among bisphosphonates and selective estrogen receptor modulators (SERMs), which are mostly used as first-line therapy and dominate the treatment market for osteoporosis patients.

Market Analysis and Insights: Global Osteoporosis Therapeutics Market
The global Osteoporosis Therapeutics market size is projected to reach US$ 12110 million by 2027, from US$ 10420 million in 2020, at a CAGR of 2.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osteoporosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osteoporosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osteoporosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osteoporosis Therapeutics market.

Global Osteoporosis Therapeutics Scope and Market Size
Osteoporosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoporosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bisphosphonates
1.2.3 Hormones
1.2.4 Strontium Ranelate
1.2.5 Raloxifene
1.2.6 Denosumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global Osteoporosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Osteoporosis Therapeutics Market Perspective (2016-2027)
2.2 Osteoporosis Therapeutics Growth Trends by Regions
2.2.1 Osteoporosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Osteoporosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Osteoporosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Osteoporosis Therapeutics Industry Dynamic
2.3.1 Osteoporosis Therapeutics Market Trends
2.3.2 Osteoporosis Therapeutics Market Drivers
2.3.3 Osteoporosis Therapeutics Market Challenges
2.3.4 Osteoporosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Osteoporosis Therapeutics Players by Revenue
3.1.1 Global Top Osteoporosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Osteoporosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Osteoporosis Therapeutics Revenue
3.4 Global Osteoporosis Therapeutics Market Concentration Ratio
3.4.1 Global Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoporosis Therapeutics Revenue in 2020
3.5 Osteoporosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Osteoporosis Therapeutics Product Solution and Service
3.7 Date of Enter into Osteoporosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Osteoporosis Therapeutics Breakdown Data by Type
4.1 Global Osteoporosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Osteoporosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Osteoporosis Therapeutics Breakdown Data by Application
5.1 Global Osteoporosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Osteoporosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Osteoporosis Therapeutics Market Size (2016-2027)
6.2 North America Osteoporosis Therapeutics Market Size by Type
6.2.1 North America Osteoporosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Osteoporosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Osteoporosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Osteoporosis Therapeutics Market Size by Application
6.3.1 North America Osteoporosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Osteoporosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Osteoporosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Osteoporosis Therapeutics Market Size by Country
6.4.1 North America Osteoporosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Osteoporosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Osteoporosis Therapeutics Market Size (2016-2027)
7.2 Europe Osteoporosis Therapeutics Market Size by Type
7.2.1 Europe Osteoporosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Osteoporosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Osteoporosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Osteoporosis Therapeutics Market Size by Application
7.3.1 Europe Osteoporosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Osteoporosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Osteoporosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Osteoporosis Therapeutics Market Size by Country
7.4.1 Europe Osteoporosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Osteoporosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Osteoporosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Osteoporosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Osteoporosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Osteoporosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Osteoporosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Osteoporosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Osteoporosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Osteoporosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Osteoporosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Osteoporosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Osteoporosis Therapeutics Market Size (2016-2027)
9.2 Latin America Osteoporosis Therapeutics Market Size by Type
9.2.1 Latin America Osteoporosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Osteoporosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Osteoporosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Osteoporosis Therapeutics Market Size by Application
9.3.1 Latin America Osteoporosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Osteoporosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Osteoporosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Osteoporosis Therapeutics Market Size by Country
9.4.1 Latin America Osteoporosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Osteoporosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Osteoporosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Osteoporosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Osteoporosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Osteoporosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Osteoporosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Osteoporosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Osteoporosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Warner Chilcott
11.1.1 Warner Chilcott Company Details
11.1.2 Warner Chilcott Business Overview
11.1.3 Warner Chilcott Osteoporosis Therapeutics Introduction
11.1.4 Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.1.5 Warner Chilcott Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Osteoporosis Therapeutics Introduction
11.2.4 Merck & Co. Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.2.5 Merck & Co. Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Osteoporosis Therapeutics Introduction
11.3.4 Roche Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Osteoporosis Therapeutics Introduction
11.4.4 Novartis Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Ono
11.5.1 Ono Company Details
11.5.2 Ono Business Overview
11.5.3 Ono Osteoporosis Therapeutics Introduction
11.5.4 Ono Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.5.5 Ono Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Osteoporosis Therapeutics Introduction
11.6.4 Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.6.5 Astellas Pharma Recent Development
11.7 Procter & Gamble
11.7.1 Procter & Gamble Company Details
11.7.2 Procter & Gamble Business Overview
11.7.3 Procter & Gamble Osteoporosis Therapeutics Introduction
11.7.4 Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.7.5 Procter & Gamble Recent Development
11.8 Sumitomo Pharmaceuticals
11.8.1 Sumitomo Pharmaceuticals Company Details
11.8.2 Sumitomo Pharmaceuticals Business Overview
11.8.3 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Introduction
11.8.4 Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.8.5 Sumitomo Pharmaceuticals Recent Development
11.9 Servier
11.9.1 Servier Company Details
11.9.2 Servier Business Overview
11.9.3 Servier Osteoporosis Therapeutics Introduction
11.9.4 Servier Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.9.5 Servier Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Osteoporosis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Osteoporosis Therapeutics Introduction
11.11.4 Pfizer Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Osteoporosis Therapeutics Introduction
11.12.4 Amgen Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Chugai
11.13.1 Chugai Company Details
11.13.2 Chugai Business Overview
11.13.3 Chugai Osteoporosis Therapeutics Introduction
11.13.4 Chugai Revenue in Osteoporosis Therapeutics Business (2016-2021)
11.13.5 Chugai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Osteoporosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bisphosphonates
Table 3. Key Players of Hormones
Table 4. Key Players of Strontium Ranelate
Table 5. Key Players of Raloxifene
Table 6. Key Players of Denosumab
Table 7. Key Players of Others
Table 8. Global Osteoporosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Osteoporosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Osteoporosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Osteoporosis Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Osteoporosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Osteoporosis Therapeutics Market Share by Regions (2022-2027)
Table 14. Osteoporosis Therapeutics Market Trends
Table 15. Osteoporosis Therapeutics Market Drivers
Table 16. Osteoporosis Therapeutics Market Challenges
Table 17. Osteoporosis Therapeutics Market Restraints
Table 18. Global Osteoporosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Osteoporosis Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Therapeutics as of 2020)
Table 21. Ranking of Global Top Osteoporosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Osteoporosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Osteoporosis Therapeutics Product Solution and Service
Table 25. Date of Enter into Osteoporosis Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Osteoporosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Osteoporosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Osteoporosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Osteoporosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Osteoporosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Osteoporosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Osteoporosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Warner Chilcott Company Details
Table 66. Warner Chilcott Business Overview
Table 67. Warner Chilcott Osteoporosis Therapeutics Product
Table 68. Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Warner Chilcott Recent Development
Table 70. Merck & Co. Company Details
Table 71. Merck & Co. Business Overview
Table 72. Merck & Co. Osteoporosis Therapeutics Product
Table 73. Merck & Co. Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Merck & Co. Recent Development
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Osteoporosis Therapeutics Product
Table 78. Roche Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Roche Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Osteoporosis Therapeutics Product
Table 83. Novartis Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Ono Company Details
Table 86. Ono Business Overview
Table 87. Ono Osteoporosis Therapeutics Product
Table 88. Ono Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Ono Recent Development
Table 90. Astellas Pharma Company Details
Table 91. Astellas Pharma Business Overview
Table 92. Astellas Pharma Osteoporosis Therapeutics Product
Table 93. Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Astellas Pharma Recent Development
Table 95. Procter & Gamble Company Details
Table 96. Procter & Gamble Business Overview
Table 97. Procter & Gamble Osteoporosis Therapeutics Product
Table 98. Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Procter & Gamble Recent Development
Table 100. Sumitomo Pharmaceuticals Company Details
Table 101. Sumitomo Pharmaceuticals Business Overview
Table 102. Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Sumitomo Pharmaceuticals Recent Development
Table 104. Servier Company Details
Table 105. Servier Business Overview
Table 106. Servier Osteoporosis Therapeutics Product
Table 107. Servier Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Servier Recent Development
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Business Overview
Table 111. Eli Lilly Osteoporosis Therapeutics Product
Table 112. Eli Lilly Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Eli Lilly Recent Development
Table 114. Pfizer Company Details
Table 115. Pfizer Business Overview
Table 116. Pfizer Osteoporosis Therapeutics Product
Table 117. Pfizer Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Pfizer Recent Development
Table 119. Amgen Company Details
Table 120. Amgen Business Overview
Table 121. Amgen Osteoporosis Therapeutics Product
Table 122. Amgen Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 123. Amgen Recent Development
Table 124. Chugai Company Details
Table 125. Chugai Business Overview
Table 126. Chugai Osteoporosis Therapeutics Product
Table 127. Chugai Revenue in Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 128. Chugai Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoporosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Bisphosphonates Features
Figure 3. Hormones Features
Figure 4. Strontium Ranelate Features
Figure 5. Raloxifene Features
Figure 6. Denosumab Features
Figure 7. Others Features
Figure 8. Global Osteoporosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Osteoporosis Therapeutics Report Years Considered
Figure 13. Global Osteoporosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Osteoporosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Osteoporosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Osteoporosis Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Osteoporosis Therapeutics Market Share by Players in 2020
Figure 18. Global Top Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Osteoporosis Therapeutics Revenue in 2020
Figure 20. Global Osteoporosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Osteoporosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Osteoporosis Therapeutics Market Share by Region (2016-2027)
Figure 42. China Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Warner Chilcott Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 62. Merck & Co. Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 65. Ono Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 66. Astellas Pharma Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 67. Procter & Gamble Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 68. Sumitomo Pharmaceuticals Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 69. Servier Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 72. Amgen Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 73. Chugai Revenue Growth Rate in Osteoporosis Therapeutics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.